Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 20/20 | 0.48 |
| ▸ | ITGB6 | P18564 | 15/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 11/20 | 0.44 |
| ▸ | ITGB5 | P18084 | 3/20 | 0.44 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28568780 | 0.99 | ITGAV (0.47) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| Hydrochloric Acid SCHEMBL21774624 | 0.99 | ITGAV (0.47) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| Hydrochloric Acid SCHEMBL21774625 | 0.99 | ITGAV (0.47) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| Hydrochloric Acid SCHEMBL28568782 | 0.99 | ITGAV (0.47) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| Hydrochloric Acid SCHEMBL31072017 | 0.99 | ITGAV (0.47) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL19384679 | 0.88 | ITGAV (0.52) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL17640902 | 0.88 | ITGAV (0.52) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| Hydrochloric Acid SCHEMBL20305074 | 0.87 | ITGAV (0.51) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| Hydrochloric Acid SCHEMBL20305071 | 0.87 | ITGAV (0.51) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL21774615 | 0.84 | ITGAV (0.47) | ITGAVITGB6ITGB3ITGB5ITGB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020047239-A1 | INHIBITING αV β6 INTEGRIN | MORPHIC THERAPEUTIC, INC. (US) | 2020-03-05 | — | — | WO | disclosed |